Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Litchfield

Showing results (31-40 of 96) with videos related to

Pageof 10
Sort By:
Nature Communications|October 28, 2015
Identification of four new susceptibility loci for testicular germ cell tumourKevin Litchfield, Amy Holroyd, Amy Lloyd, et al.
Journal of Immunotherapy and Precision Oncology|May 22, 2023
Translational Studies Using the MALT1 Inhibitor (<i>S</i>)-Mepazine to Induce Treg Fragility and Potentiate Immune Checkpoint Therapy in CancerMauro Di Pilato, Yun Gao, Yi Sun, et al.
Cancer Research|April 18, 2024
CRISPR-Cas9 Screening Identifies KRAS-Induced COX2 as a Driver of Immunotherapy Resistance in Lung CancerJesse Boumelha, Andrea de Castro, Nourdine Bah, et al.
Nature Communications|December 21, 2016
Rare disruptive mutations in ciliary function genes contribute to testicular cancer susceptibilityKevin Litchfield, Max Levy, Darshna Dudakia, et al.
Molecular Cancer Research : MCR|January 21, 2026
Contrasting features of papillary and chromophobe renal cell carcinoma revealed by whole genome sequencingRichard Culliford, Charlie Mills, Daniel Chubb, et al.
Human Molecular Genetics|April 20, 2022
Frequency of pathogenic germline variants in cancer susceptibility genes in 1336 renal cell carcinoma casesBryndis Yngvadottir, Avgi Andreou, Laia Bassaganyas, et al.
Human Molecular Genetics|June 20, 2014
Pathway-based analysis of GWAs data identifies association of sex determination genes with susceptibility to testicular germ cell tumorsRoelof Koster, Nandita Mitra, Kurt D'Andrea, et al.
Oncotarget|March 22, 2018
Validation of loci at 2q14.2 and 15q21.3 as risk factors for testicular cancerChey Loveday, Kevin Litchfield, Max Levy, et al.
Nature Communications|July 15, 2024
Whole genome sequencing refines stratification and therapy of patients with clear cell renal cell carcinomaRichard Culliford, Samuel E D Lawrence, Charlie Mills, et al.
The Journal of Clinical Investigation|April 29, 2021
Melanoma dedifferentiation induced by IFN-γ epigenetic remodeling in response to anti-PD-1 therapyYeon Joo Kim, Katherine M Sheu, Jennifer Tsoi, et al.
Pageof 10

Showing results (31-40 of 96) with videos related to

Sort By:
Pageof 10
Nature Communications|October 28, 2015
Identification of four new susceptibility loci for testicular germ cell tumourKevin Litchfield, Amy Holroyd, Amy Lloyd, et al.
Journal of Immunotherapy and Precision Oncology|May 22, 2023
Translational Studies Using the MALT1 Inhibitor (<i>S</i>)-Mepazine to Induce Treg Fragility and Potentiate Immune Checkpoint Therapy in CancerMauro Di Pilato, Yun Gao, Yi Sun, et al.
Cancer Research|April 18, 2024
CRISPR-Cas9 Screening Identifies KRAS-Induced COX2 as a Driver of Immunotherapy Resistance in Lung CancerJesse Boumelha, Andrea de Castro, Nourdine Bah, et al.
Nature Communications|December 21, 2016
Rare disruptive mutations in ciliary function genes contribute to testicular cancer susceptibilityKevin Litchfield, Max Levy, Darshna Dudakia, et al.
Molecular Cancer Research : MCR|January 21, 2026
Contrasting features of papillary and chromophobe renal cell carcinoma revealed by whole genome sequencingRichard Culliford, Charlie Mills, Daniel Chubb, et al.
Human Molecular Genetics|April 20, 2022
Frequency of pathogenic germline variants in cancer susceptibility genes in 1336 renal cell carcinoma casesBryndis Yngvadottir, Avgi Andreou, Laia Bassaganyas, et al.
Human Molecular Genetics|June 20, 2014
Pathway-based analysis of GWAs data identifies association of sex determination genes with susceptibility to testicular germ cell tumorsRoelof Koster, Nandita Mitra, Kurt D'Andrea, et al.
Oncotarget|March 22, 2018
Validation of loci at 2q14.2 and 15q21.3 as risk factors for testicular cancerChey Loveday, Kevin Litchfield, Max Levy, et al.
Nature Communications|July 15, 2024
Whole genome sequencing refines stratification and therapy of patients with clear cell renal cell carcinomaRichard Culliford, Samuel E D Lawrence, Charlie Mills, et al.
The Journal of Clinical Investigation|April 29, 2021
Melanoma dedifferentiation induced by IFN-γ epigenetic remodeling in response to anti-PD-1 therapyYeon Joo Kim, Katherine M Sheu, Jennifer Tsoi, et al.
Pageof 10